Literature DB >> 7028042

In vitro biotransformations of [14C]captopril in the blood of rats, dogs and humans.

K K Wong, S Lan, B H Migdalof.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028042     DOI: 10.1016/0006-2952(81)90532-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  A rat model of captopril immunogenicity.

Authors:  A L Foster; J W Coleman
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

2.  Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure.

Authors:  T R Shaw; F M Duncan; B C Williams; E Crichton; S A Thomson; J R Davis; M Rademaker; C R Edwards
Journal:  Br Heart J       Date:  1985-08

Review 3.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

4.  Ineffectiveness of captopril in reducing cystine excretion in cystinuric children.

Authors:  H Michelakakis; D Delis; V Anastasiadou; C Bartsocas
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation.

Authors:  I R Wilding; S S Davis; M Bakhshaee; H N Stevens; R A Sparrow; J Brennan
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

6.  Drug-specific antibodies in patients receiving captopril.

Authors:  J W Coleman; J H Yeung; D H Roberts; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.

Authors:  J Hoyer; K L Schulte; T Lenz
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

8.  The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: comparison with patients with normal renal function.

Authors:  O H Drummer; B S Workman; P J Miach; B Jarrott; W J Louis
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 9.  Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.

Authors:  K L Duchin; D N McKinstry; A I Cohen; B H Migdalof
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 10.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.